State Control of Medicines and Medical Devices in Russian Federation

Size: px
Start display at page:

Download "State Control of Medicines and Medical Devices in Russian Federation"

Transcription

1 Federal Service for Surveillance in Healthcare State Control of Medicines and Medical Devices in Russian Federation Ph.D., Elena Astapenko The Head of the Department of organization of state control and registration of medical devices

2 Structure and Competences of Roszdravnadzor Federal Service for Surveillance in Healthcare (Roszdravnadzor) Central Office, including 8 Divisions Quality and safety control of healthcare practices 11 Federal laboratory complexes Control in the sphere of medicines circulation 80 Regional Offices Control of medical devices circulation

3 State Control System in the Sphere of Circulation of Medicines Functions of Roszdravnadzor in the sphere of circulation of medicines Licensing of pharmaceutical activity (licensing control) Federal state supervision in the sphere of circulation of medicines (includes quality control of medicines) Selective quality control of medicines Groups of drugs The elements of the system of state quality control of medicines Central apparatus of Roszdravnadzor and its territorial bodies Testing laboratories Unified information system The system of quality in organizations manufacturing medicines, wholesale and retail pharmaceutical organizations Information about the number of withdrawn drugs for the period months 2015 The number of withdrawn drugs months 2015 Insufficient drugs Drugs, withdrawn by the manufacturer Counterfeit of pharmaceutical substances and drugs, made from them Counterfeit drugs Counterfeit medicines Total

4 Federal State Budgetary Institution «Information and Methodological Center of Expertise, Stocking and Analysis of Medical Products Circulation» of Roszdravnadzor Volga Federal District 1 laboratory complex and 1 mobile lab (Kazan) North-West Federal District 1 laboratory complex and 1 mobile lab (Saint-Petersburg) Central Federal District 3 laboratory complexes (Moscow, Kursk, Tambov) 1 mobile lab (Moscow) Ural Federal District 1 laboratory complex and 1 mobile lab (Ekaterinburg) South Federal District, Crimean Federal District 2 laboratory complexes, 2 mobile labs (Rostov-on-Don, Simferopol) Far-East Federal District 1 laboratory complex and 1 mobile lab (Khabarovsk) North Caucasus Federal district 2 laboratory complexes (Stavropol, Gudermes) 1 mobile lab (Gudermes) Siberia Federal District 1 laboratory complex and 1 mobile lab (Krasnoyarsk)

5 Federal State Budgetary Institution «Information and Methodological Center of Expertise, Stocking and Analysis of Medical Products Circulation» of Roszdravnadzor Organizational department Analytical laboratory Microbiological laboratory Pharmacological laboratory Immunological laboratory (Krasnoyarsk, Moscow, Yaroslavl) Mobile laboratory 5

6 Organization of Random Control of Medicines Manufacturers and importers of medicines Roszdravnadzor s information system Forming of random control plan Submitting of lot and batches data for medicines entering the market Acquired processing information Forwarding of the task to Roszdravnadzor s regional offices Testing laboratories of Roszdravnadzor Roszdravnadzor s regional offices Medicines samples testing Selection of samples

7 Decision Making on the Results of Random Quality Control of Medicines Roszdravnadzor Collecting results of medicines testing Positive conclusion Negative conclusion Repeated negative conclusion Information is published at Roszdravnadzor web-site Decision to withdraw and destroy a lot. Information is published at Roszdravnadzor web-site Batch-to-batch control on three batches, at the laboratories of Roszdravnadzor Decision to remove from batch-to-batch control in case of positive results Inspection In case of GMP incompliance - suspension of application of a medicine till the correction of identified deficiencies

8 Improvement of Federal State Control (Supervision) in the Sphere of Circulation of Medicines Federal Law dated No 429-FZ On amendments to the federal law "On circulation of medicines (entered into force on the 1 July 2015) Selective quality control of medicines was implemented. (the order of Roszdravnadzor dated «About approval of the procedure for implementation of selective quality control of medicinal products for medical use») Amendments to pharmacovigilance arrangements Amendments to the Federal Law dated No 294-FZ «On the protection of rights of legal entities and individual entrepreneurs when exercising state control (supervision) and municipal control» Are not required: prior approval from prosecutors to the timing of unscheduled inspections of subjects of circulation of medicines, advance notification of legal entities and individual entrepreneurs about the beginning of the unscheduled inspection. The prosecution bodies are notified about an unscheduled inspections of subjects of circulation of medicines by submitting the relevant documents within three business days after the end of the specified unscheduled inspections.

9 The General Scheme of Participants and Flows in the System for Monitoring of the Civil Turnover of Medicines The monitoring of civil turnover of medicines from the manufacturer to the final consumer is provided: Way I: 1. Manufacture of a medicine 2. Wholesale trade 3. Retail trade, usage by hospitals Way II: 1. Manufacture of a medicine 2. Retail trade, usage by hospitals Medicine Retail Patient Way I Manufacture Distributor Distributor 2 N Distributor 1 Way II Hospital

10 Pangea Operation Control measures together with representatives of law enforcement and customs authorities Screening quality of medicines in mobile labs using non-destructive NIR spectrometry method Examination of questionable samples in the federal laboratory complexes Advisory and information support to participants of the operation Informational materials, list of counterfeit drugs and APIs and also information about installed signs of falsification

11 Definition of Medical Device in Russian Federation The Law 323-FZ dated The basis of health protection in the Russian Federation Article 38. Medical devices. Medical devices are any instrument, apparatus, appliances, equipment, materials and other devices used for medical purposes alone or in combination with each other as well as with other accessories required for use of these devices for their purpose, including special software and designed by the manufacturer for the prevention, diagnosis, treatment and rehabilitation of diseases, monitoring the state of the human body, for medical research, rehabilitation, replacement, changes of anatomical structure or physiological functions, prevention or termination of pregnancy, which function is not implemented by pharmacological, immunological, genetic or metabolic effects on the human body. Medical devices may be recognized as interchangeable if they are comparable in functionality, quality and technical characteristics and can replace each other. 11

12 Stages of Circulation of Medical Devices Technical trials Toxicity studies Clinical trials Utilization and disposal Expertise of quality, efficacy and safety Repairs Application, operation, including maintanance Roszdravnadzor Production Manufacturing Import, export Installation, adjustment Sales Transportation Storage

13 Methods of State Control of Circulation of Medical Devices Audits of the subjects of circulation of medical devices compliance with the rules of medical devices circulation approved by the Russian Ministry of Health Permissions for imports of medical devices for the purposes of state registration Monitoring of safety of medical devices

14 Functions of Roszdravnadzor s Subordinate Expert Organizations Expertise of quality, efficiency and safety of medical devices: for the purposes of registration of medical devices within the framework of control measures Conducting technical testing of medical devices Toxicological studies Monitoring the quality, effectiveness and safety of medical devices

15 Federal State Budgetary Institution All-Russian Scientific-research and Test Institute for Medical Engineering of Roszdravnadzor Testing laboratory of medical supplies and tools Technical tests laboratory of medical devices Testing laboratory of mobile complexes for medical purposes Testing laboratory of instruments and equipment for functional diagnostics and physiotherapy Testing laboratory of medical devices software Testing laboratory of instruments and apparatus for radiation diagnosis and therapy Testing laboratory of electromagnetic compatibility of medical equipment Testing laboratory of instruments and apparatus for medical laboratory tests Department of toxicology testing and research materials and medical devices Laboratory of microbiological researching in medical devices 15

16 Statistical Data on Identified Medical Devices months 2015 More than 62% relate to the following types: physiotherapy equipment diagnostic equipment in vitro reagent sets prosthetic and orthopedic devices medical clothing and protective equipment Substandard medical device units 9 months units Falsified medical device unit 9 months units

17 Improvement of Federal State Control (Supervision) in the Sphere of Medicines and Medical Devices Circulation Amendments to the Administrative Code of the Russian Federation Article Violation of the rules in the field of circulation of medical devices (since ) Article Circulation of falsified, counterfeit, substandard and unregistered medicines, medical devices and the turnover of falsified biologically active supplements (since ) Type of medicine or medical device Falsified medicine Falsified medical device Counterfeit medicine Counterfeit medical device Substandard medicine Substandard medical device Unregistered medicine Activity Manufacture, sale or import Sale or import Manufacture, sale or import Fines citizens thsd rubles officials thsd rubles individual entrepreneurs thsd rubles or up to 90 days legal entities 1-5 mln rubles or up to 90 days Amendments to the Criminal Code of the Russian Federation (since ): illegal manufacture of drugs and medical devices (Article ); circulation of counterfeit, substandard and unregistered medicines, medical devices and trafficking of falsified biologically active supplements (Article ); forgery of documents for medicines or medical devices, or forgery of the packaging of medicines or medical devices (article ) in a large size (more than 100 thousand rubles) imprisonment up to 12 years; fine up to 5 million rubles. deprivation of the right to engage in professional activities up to 10 years.

18 Federal Service for Surveillance in Healthcare Thank you for your attention! PhD., Astapenko E.M. Head of the Department of organization of state control and registration of medical devices

Russian Federation. Chapter 12. By Julianna Tabastajewa and Svetlana Rudevich

Russian Federation. Chapter 12. By Julianna Tabastajewa and Svetlana Rudevich Chapter 12 Russian Federation By Julianna Tabastajewa and Svetlana Rudevich Legal System The Russian Federation is a federal state consisting of a total of 83 republics, regions, federal cities, autonomous

More information

MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION (Minzdrav of Russia) Moscow

MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION (Minzdrav of Russia) Moscow 1 MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION (Minzdrav of Russia) ORDER 9 January 2014 No. 2n Moscow On Approval of the Procedure for Medical Device Conformity Assessment in the Form of Technical Trials,

More information

Amendments to the Federal Law On Circulation of Pharmaceuticals

Amendments to the Federal Law On Circulation of Pharmaceuticals Amendments to the Federal Law On Circulation of Pharmaceuticals March 2015 / Issue No. 40 [111] What s new? The Federal Law On amendment of the Federal Law On circulation of pharmaceuticals No. 429-FZ

More information

THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION ORDER. January 19, Moscow

THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION ORDER. January 19, Moscow Stamp: The Ministry of Justice of the Russian Federation REGISTERED Registration No.45896 dated March 10, 2017 THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION ORDER January 19, 2017 No.11n Moscow On approval

More information

ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA

ISPE Annual Meeting 29 October 1 November 2017 San Diego, CA Ministry of Industry and Trade/ Department of pharmaceutical and medical industry development Moscow September 22, 2017 MEDICINES CIRCULATION SYSTEM IN THE RUSSIAN FEDERATION Ministry of Healthcare Medicines

More information

21 November 1995 No.170-FZ RUSSIAN FEDERATION FEDERAL LAW ON ATOMIC ENERGY USE

21 November 1995 No.170-FZ RUSSIAN FEDERATION FEDERAL LAW ON ATOMIC ENERGY USE 21 November 1995 No.170-FZ RUSSIAN FEDERATION FEDERAL LAW ON ATOMIC ENERGY USE Approved by the State Duma on October 20, 1995 (in version of Federal Laws of 10.02.1997 N 28-FZ, of 10.07.2001 N 94-FZ, of

More information

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,

More information

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Status in RSA: 2 December 2015 Legislation: Bill 6D, 2014 Defines MD and IVDs Licensing of Manufacturers,

More information

The Accounts Chamber of the Russian Federation. «Management of Hazardous and Radioactive Waste in the Russian Federation»

The Accounts Chamber of the Russian Federation. «Management of Hazardous and Radioactive Waste in the Russian Federation» The Accounts Chamber of the Russian Federation «Management of Hazardous and Radioactive Waste in the Russian Federation» In Russia competent government bodies control the handling of spent nuclear fuel

More information

Medical Devices. LITHUANIA LAWIN Lideika, Petrauskas, Valiunas ir partneriai

Medical Devices. LITHUANIA LAWIN Lideika, Petrauskas, Valiunas ir partneriai Medical Devices LITHUANIA LAWIN Lideika, Petrauskas, Valiunas ir partneriai CONTACT INFORMATION Ruta Pumputiene LAWIN Lideika, Petrauskas, Valiunas ir partneriai Jogailos str. 9 / 1, LT-01116 Vilnius,

More information

Data Collection Tools Functions, Indicators & Sub-Indicators

Data Collection Tools Functions, Indicators & Sub-Indicators Data Collection Tools 27- Functions, Indicators & A. National regulatory system Indicator RS1: Legal framework for establishment of a regulatory system, mandate and enforcement power for each function

More information

Chapter I. General Provisions

Chapter I. General Provisions FEDERAL LAW NO. 109-FZ OF JULY 19, 1997 ON THE SAFE HANDLING OF PESTICIDES AND AGROCHEMICALS (with the Amendments and Additions of January 10, 2003, June 29, 2004, October 16, 2006) Adopted by the State

More information

G/TBT/N/MYS/8 Proposal to enforce the Control of Drugs and Cosmetics Regulations 1984 on veterinary medicinal products.

G/TBT/N/MYS/8 Proposal to enforce the Control of Drugs and Cosmetics Regulations 1984 on veterinary medicinal products. G/TBT/N/MYS/8 Proposal to enforce the Control of Drugs and Cosmetics Regulations 1984 on veterinary medicinal products. The Health Minister of Malaysia, as conferred by subregulation 1(2) of the Control

More information

Pharmacovigilance System in Russia and the EAEU

Pharmacovigilance System in Russia and the EAEU Pharmacovigilance System in Russia and the EAEU Authors: Sergey Simeniv CEO X7 Research, CRO; Olga Latysheva Head of Pharmacovigilance Department X7 Research, CRO; Dmitry Kryuchkov Executive Director X7

More information

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015

Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Overview Global status on MD and IVDs National status on MD and IVDs Legislation Key player and Responsibilities

More information

KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar

KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar Kyung-Min Baek, Ph.D. Recombinant Protein Products Division Korea Food and Drug Administration(KFDA) Biopharmaceuticals A biopharmaceutical

More information

Materials Management Traceability, CEPs and managing non-conforming sites

Materials Management Traceability, CEPs and managing non-conforming sites Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain

More information

Guidelines on import procedures for pharmaceutical products

Guidelines on import procedures for pharmaceutical products Guidelines on import procedures for pharmaceutical products INTRODUCTION Public health concerns demand that the manufacture of pharmaceutical products and their subsequent handling within the distribution

More information

RUSSIAN FEDERATION FEDERAL LAW On Uniformity of Measurements

RUSSIAN FEDERATION FEDERAL LAW On Uniformity of Measurements RUSSIAN FEDERATION FEDERAL LAW On Uniformity of Measurements Adopted State Duma June 11, 2008 Approved Federation Council June 18, 2008 Chapter 1. GENERAL PROVISION Article 1. Objectives and scope of the

More information

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS

GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no. +220 4380632 GUIDELINES FOR REGISTRATION OF IMPORTERS AND FOR THE IMPORTATION OF MEDICINES AND RELATED PRODUCTS Document no: MCA/IMPG/2017/1

More information

Food and Drug Administration (FDA) 101

Food and Drug Administration (FDA) 101 Food and Drug Administration (FDA) 101 What is the Food and Drug Administration (FDA)? The FDA is an agency within the U.S. Department of Health and Human Services that is responsible for protecting the

More information

Draft Federal Law On Amendment of Selected Legislative Acts of the Russian Federation

Draft Federal Law On Amendment of Selected Legislative Acts of the Russian Federation Draft Federal Law On Amendment of Selected Legislative Acts of the Russian Federation Published on 10.28.2005 Article 1 Para 4 of Article 8 of the RF law, On Closed Administrative Territories (#3297-1

More information

STRATEGIC PLAN OF THE STATE INSTITUTE FOR DRUG CONTROL FOR Public Section

STRATEGIC PLAN OF THE STATE INSTITUTE FOR DRUG CONTROL FOR Public Section STRATEGIC PLAN OF THE STATE INSTITUTE FOR DRUG CONTROL FOR 2016-2020 Public Section 1 1. FOREWORD The document SÚKL Strategic Plan for 2016-2020 (hereinafter referred to as the Strategy ) summarises the

More information

Tuesday, 21 October Jang Yong Choi

Tuesday, 21 October Jang Yong Choi Tuesday, 21 October 2014 Jang Yong Choi Contents Status of Medical Device Industry in Korea MFDS Organization and Responsibilities Medical Device Regulation Overview Medical Device Regulation Updates I.

More information

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER

More information

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland

Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance

More information

INDO AFRICA PHARMA MEET 24-27TH SEPT, Hotel Marriot Hussain Sagar Lane, Road, Hyderabad India SPONSORED BY PHARMEXCIL

INDO AFRICA PHARMA MEET 24-27TH SEPT, Hotel Marriot Hussain Sagar Lane, Road, Hyderabad India SPONSORED BY PHARMEXCIL INDO AFRICA PHARMA MEET 24-27TH SEPT, 2009 Hotel Marriot Hussain Sagar Lane, Road, Hyderabad India SPONSORED BY PHARMEXCIL Drug Registration procedures in Tanzania Nditonda B. Chukilizo and Adonis Bitegeko

More information

GUIDELINES FOR MEDICAL DEVICES REGISTRATION

GUIDELINES FOR MEDICAL DEVICES REGISTRATION GUIDELINES FOR MEDICAL DEVICES REGISTRATION FOREWORD The purpose of Drug Registration is to ensure that a pharmaceutical product has been adequately tested and evaluated for safety, efficacy and quality,

More information

d) ensure formulation of guidelines on countering corruption. 2. The Government of the Russian Federation should:

d) ensure formulation of guidelines on countering corruption. 2. The Government of the Russian Federation should: National Anti-Corruption Plan for 2010-2011 (Approved by the President of the Russian Federation on 31 July 2008 Пр-1568 (as contained in Decree of the President of the Russian Federation 460 of 13 April

More information

Korean Medical Devices Regulations

Korean Medical Devices Regulations Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,

More information

FEDERAL ENVIRONMENTAL, INDUSTRIAL AND NUCLEAR SUPERVISION SERVICE OF RUSSIA (ROSTECHNADZOR) LEGAL REGULATION OF INDUSTRIAL SAFETY

FEDERAL ENVIRONMENTAL, INDUSTRIAL AND NUCLEAR SUPERVISION SERVICE OF RUSSIA (ROSTECHNADZOR) LEGAL REGULATION OF INDUSTRIAL SAFETY FEDERAL ENVIRONMENTAL, INDUSTRIAL AND NUCLEAR SUPERVISION SERVICE OF RUSSIA LEGAL REGULATION OF INDUSTRIAL SAFETY INTERNATIONAL COMMITMENTS OF THE RUSSIAN FEDERATION Convention on the Transboundary Effects

More information

Due diligence in the European medical devices industry

Due diligence in the European medical devices industry Due diligence in the European medical devices industry Alison Dennis, Reed Smith LLP www.practicallaw.com/0-205-5707 As the medical devices industry is highly regulated, determining a target company's

More information

On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment

On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment Resolution of the Government of the Republic of Kazakhstan No. 711 of 31 May 2012

More information

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI

PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI PHARMACY, MEDICINES & POISONS BOARD GUIDELINES FOR RECALL OF MEDICINES AND HEALTH PRODUCTS IN MALAWI Draft September 2015 1. INTRODUCTION The Malawi Pharmacy Medicines and Poisons Board (PMPB) was established

More information

Application for registration certificate to operate a retail pharmacy 5, ,000.00

Application for registration certificate to operate a retail pharmacy 5, ,000.00 Appendix 3: Pharmaceutical Regulatory Authority Schedule of Fees, 2010 A. RETAIL / HOSPITAL PHARMACY FEE UNITS (1 fee Unit = K180) APPLICATION FEES (ZMK) 1 2 Application for registration certificate to

More information

Post Referendum Briefing: Business Continues. September 2016

Post Referendum Briefing: Business Continues. September 2016 Post Referendum Briefing: Business Continues September 2016 The Agency 1. The Medicines and Healthcare products Regulatory Agency is an executive agency of the UK Department of Health (DH). The Agency

More information

TERMS AND DEFINITIONS

TERMS AND DEFINITIONS TERMS AND DEFINITIONS Advisory notice A notice issued by the organization, subsequent to delivery of the medical device, to provide supplementary information and/or to advise what action should be taken

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Licence to act as a Wholesaler or Distributor MEDICINES CONTROL COUNCIL GUIDELINES FOR LICENCE TO ACT AS A WHOLESALER or DISTRIBUTOR This guideline is intended to provide recommendations to applicants

More information

BULGARIAN PHARMACEUTICAL POLICY AND LEGISLATION IN THE CONTEXT OF THE EU ACCESSION

BULGARIAN PHARMACEUTICAL POLICY AND LEGISLATION IN THE CONTEXT OF THE EU ACCESSION BULGARIAN PHARMACEUTICAL POLICY AND LEGISLATION IN THE CONTEXT OF THE EU ACCESSION DR SVETLANA SPASSOVA DIRECTOR NATIONAL HEALTH POLICY MINISTRY OF HEALTH European Health Conference 29th September 2006

More information

Medical Devices. LATVIA LAWIN Klavins & Slaidins

Medical Devices. LATVIA LAWIN Klavins & Slaidins Medical Devices LATVIA LAWIN Klavins & Slaidins CONTACT INFORMATION Sarmis Spilbergs LAWIN Klavins & Slaidins Elizabetes 15, Riga, LV 1010, Latvia +371 67814848 sarmis.spilbergs@lawin.lv www.lawin.com

More information

Pharmaceutical law legal FramewOrK

Pharmaceutical law legal FramewOrK Pharmaceutical law LEGAL FRAMEWORK 2015 CONTENTS: Hardly any area of law has such a direct connection to human health as pharmaceutical law. This fact requires fulfillment of detailed and strict conditions

More information

Baek, Kyung-min. Recombinant Protein Products Division. Ministry of Food and Drug Safety

Baek, Kyung-min. Recombinant Protein Products Division. Ministry of Food and Drug Safety Baek, Kyung-min Recombinant Protein Products Division Ministry of Food and Drug Safety About Ministry of Food and Drug Safety Regulation for Biosimilar Principle of Biosimilar Approach Status of Biosimilar

More information

Pharmabiotics: a Regulatory Hurdle in Europe

Pharmabiotics: a Regulatory Hurdle in Europe Pharmabiotics: a Regulatory Hurdle in Europe Dr. Magali Cordaillat-Simmons PRI Executive Scientist Raleigh, NC, USA September 8th, 2014 PHARMABIOTICS: A REGULATORY HURDLE IN EUROPE I. Introduction to Pharmabiotics

More information

Overview of global registration of vaccines

Overview of global registration of vaccines Overview of global registration of vaccines by Dr. Nora Dellepiane Workshop: Global Registration and Vaccine Shortage Taipei, Taiwan 6 to 10 March 2017 Outline of the presentation The objective of medicines

More information

API EUROPEAN GMP REQUIREMENTS. Alessio Ferrari

API EUROPEAN GMP REQUIREMENTS. Alessio Ferrari API EUROPEAN GMP REQUIREMENTS Alessio Ferrari SUMMARY GUIDELINES IMPLICATIONS FOR THE INDUSTRY ARTICLE 46 (F) OF DIRECTIVE 2001/83/EC PART I EU GMP Chapter 5 OFFICIAL MEASURES TO PROTECT. PROCEDURE TO

More information

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction

More information

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005

Paths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005 Paths to Market & FDA Product Lifecycle Regulation Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005 FDA Organization U.S. Food & Drug Administration Headed by a Commissioner

More information

Regulation of Cell and Gene Therapy Products in Canada

Regulation of Cell and Gene Therapy Products in Canada Regulation of Cell and Gene Therapy Products in Canada Canadian Blood and Bone Marrow Transplant Group June 8, 2018 Nadine Kolas, PhD Senior Policy Analyst Blood, Cells, Tissues and Organs Biologics and

More information

IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU. IPA/EDQM/WHO 2012, Mumbai

IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU. IPA/EDQM/WHO 2012, Mumbai IMPLEMENTATION OF THE EU FALSIFIED MEDICINES DIRECTIVE, 2011/62/EU from the perspective of Indian manufacturers and Indian authorities IPA/EDQM/WHO 2012, Mumbai S.M.MUDDA Micro Labs Limited, Bangalore

More information

Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP

Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP Dr. K. Bangarurajan M Pharm, PhD Deputy Drugs Controller (India) CDSCO West Zone Outline Licensing Authority India - Clinical Trial: CDSCO

More information

ANNUAL REPORT ON ACTIVITIES OF THE FEDERAL ENVIRONMENTAL, INDUSTRIAL AND NUCLEAR SUPERVISION SERVICE IN 2013

ANNUAL REPORT ON ACTIVITIES OF THE FEDERAL ENVIRONMENTAL, INDUSTRIAL AND NUCLEAR SUPERVISION SERVICE IN 2013 The Federal Environmental, Industrial and Nuclear Supervision Service of Russia ANNUAL REPORT ON ACTIVITIES OF THE FEDERAL ENVIRONMENTAL, INDUSTRIAL AND NUCLEAR SUPERVISION SERVICE IN 2013 Moscow 2014

More information

Counterfeit Drugs and Supply Chain Security

Counterfeit Drugs and Supply Chain Security Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children

More information

IV. DESIGN AND OPERATION. INDUSTRIAL SAFETY

IV. DESIGN AND OPERATION. INDUSTRIAL SAFETY IV. DESIGN AND OPERATION. INDUSTRIAL SAFETY Specific actions to prevent accidents while operating offshore oil and gas fields shall be taken starting from the stage of design and/or selection of appropriate

More information

Compliance mechanisms available in Russia to ensure adherence to ethical guidelines

Compliance mechanisms available in Russia to ensure adherence to ethical guidelines Compliance mechanisms available in Russia to ensure adherence to ethical guidelines Prof. Olga Kubar, Saint Petersburg Pasteur Institute, Russia 1 Project full title: Project acronym: Type of funding scheme:

More information

WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS

WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS WHO GLOBAL BENCHMARKING TOOL (GBT) FOR EVALUATION OF NATIONAL REGULATORY SYSTEM OF MEDICAL PRODUCTS MARKET SURVEILLANCE AND CONTROL (MC): INDICATORS AND FACT SHEETS Revision VI version 1 November 2018

More information

FINAL DOCUMENT. Global Harmonization Task Force (revision of GHTF/SG1/N29:2005)

FINAL DOCUMENT. Global Harmonization Task Force (revision of GHTF/SG1/N29:2005) GHTF/SG1/N071:2012 FINAL DOCUMENT Global Harmonization Task Force (revision of GHTF/SG1/N29:2005) Title: Definition of the Terms Medical Device and In Vitro Diagnostic (IVD) Medical Device Authoring Group:

More information

Session 4: Ensuring Product Quality Throughout the Supply Chain

Session 4: Ensuring Product Quality Throughout the Supply Chain Session 4: Ensuring Product Quality Throughout the Supply Chain Potential Quality Assurance Checkpoints Within the Overall Supply Chain 1. Raw Materials / Components 2. Manufacturing 3. Packaging 6. Receiving

More information

Text of the Russian Pharma Serialization and Tracing Pilot Guidelines as translated by Google Translate

Text of the Russian Pharma Serialization and Tracing Pilot Guidelines as translated by Google Translate 1 Text of the Russian Pharma Serialization and Tracing Pilot Guidelines as translated by Google Translate Provided by RxTrace for discussion only. Do not base your compliance activities on this unofficial

More information

Impact of the IVD Regulations. Barbara Fallowfield Managing Director

Impact of the IVD Regulations. Barbara Fallowfield Managing Director Impact of the IVD Regulations Barbara Fallowfield Managing Director What will I cover today? Timelines Key Changes Classification Clinical Evidence Requirements Third Parties Vigilance and Post Marketing

More information

Adopted by the State Duma on May 22, 1998 Approved by the Federation Council on June 10, 1998

Adopted by the State Duma on May 22, 1998 Approved by the Federation Council on June 10, 1998 FEDERAL LAW NO. 89-FZ OF JUNE 24, 1998 ON PRODUCTION AND CONSUMPTION WASTE (with the Amendments and Additions of December 29, 2000, January 10, 2003, August 22, December 29, 2004, May 9, December 31, 2005,

More information

LAW OF UKRAINE. On Amendments to certain Ukrainian Laws dealing with Pesticides and Agricultural Chemicals

LAW OF UKRAINE. On Amendments to certain Ukrainian Laws dealing with Pesticides and Agricultural Chemicals LAW OF UKRAINE On Amendments to certain Ukrainian Laws dealing with Pesticides and Agricultural Chemicals The Supreme Rada of Ukraine resolves: I. To amend the following laws of Ukraine: 1. In the Law

More information

CHAPTER THE PHARMA LEGAL HANDBOOK SOUTH AFRICA

CHAPTER THE PHARMA LEGAL HANDBOOK SOUTH AFRICA CHAPTER THE PHARMA LEGAL HANDBOOK SOUTH AFRICA THE PHARMA LEGAL HANDBOOK ANSWERS ESSENTIAL QUESTIONS ABOUT THE LEGAL AND REGULATORY ENVIRONMENT FOR PHARMACEUTICALS IN SOUTH AFRICA. IT IS A MUST-HAVE FOR

More information

Update on the IVDR. Sue Spencer

Update on the IVDR. Sue Spencer Update on the IVDR Sue Spencer Caution The new regulations are draft the principles have now been agreed but the Annexes are subject to minor changes Further details will be added later pre and post application

More information

Law Messenger. Life Sciences Alert. November 2017

Law Messenger. Life Sciences Alert. November 2017 21 December 2017 Law Messenger Life Sciences Alert November 2017 EY s Russian Tax & Law practice was named a leading Tax firm in Russia in World Tax 2017, an annual guide published by the International

More information

Conditional Early Approval System for Innovative Medical Device Products (Fast-Break Scheme)

Conditional Early Approval System for Innovative Medical Device Products (Fast-Break Scheme) PSEHB Notification No. 0731-1 July 31, 2017 To: Prefectural Governors Director-General of the Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare (Official seal

More information

Regulatory Framework for Medical Device

Regulatory Framework for Medical Device Regulatory Framework for Medical Device International Seminar Safety of Health Products French Ministry of Labour, Employment and Health Paris, 26 May 2011 Peter Bischoff-Everding European Commission EU

More information

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG

REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG SCHEDULE Form 1 REPUBLIC OF MAURITIUS APPLICATION FOR REGISTRATION OF A DRUG THE REGISTRAR PHARAMCY BOARD MINISTRY OF HEALTH AND QUALITY OF LIFE MAURITIUS Fax: Telephone: TYPE OF APPLICATION HUMAN, BIOLOGICAL

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit

More information

Kingdom of Swaziland Ministry of Health. Guidelines on Import Procedures for Medicines

Kingdom of Swaziland Ministry of Health. Guidelines on Import Procedures for Medicines Kingdom of Swaziland Ministry of Health Guidelines on Import Procedures for Medicines August 2012 Kingdom of Swaziland Guidelines on Import Procedures for Medicines August 2012 Ministry of Health P. O.

More information

GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA

GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA MEDICINES CONTROL AGENCY 54 Kairaba Avenue, Pipeline, The Gambia. Tel.no. +220 4380632 GUIDELINES FOR REGISTRATION OF MEDICINES IN THE GAMBIA Document no: MCA/MRG/2017/1 Date of issue: 25 th July 2017

More information

IVD Regulation Update

IVD Regulation Update IVD Regulation Update BSI Annual Roadshow October 2016 1 IVDR Overview - Update 2 Classification & Conformity Assessment Medical Devices Coordination Group (MDCG) Electronic systems (Eudamed) Summary of

More information

378/2007 Coll. ACT of 6 December 2007 on Pharmaceuticals and on Amendments to Some Related Acts (the Act on Pharmaceuticals)

378/2007 Coll. ACT of 6 December 2007 on Pharmaceuticals and on Amendments to Some Related Acts (the Act on Pharmaceuticals) 378/2007 Coll. ACT of 6 December 2007 on Pharmaceuticals and on Amendments to Some Related Acts (the Act on Pharmaceuticals) Amendment: 124/2008 Sb. Amendment: 296/2008 Sb. Amendment: 141/2009 Sb. Amendment:

More information

Orphan Designation System in Japan. 10, March 2014 Ministry of Health, Labour and Welfare

Orphan Designation System in Japan. 10, March 2014 Ministry of Health, Labour and Welfare Orphan Designation System in Japan 10, March 2014 Ministry of Health, Labour and Welfare Background of the Orphan Designation System Before the system had been implemented, the R&D on medicines for rare

More information

Recommendations on Medical Device and IVD Field Safety Corrective Actions and Recalls using Unique Device Identifiers & GS1 Standards

Recommendations on Medical Device and IVD Field Safety Corrective Actions and Recalls using Unique Device Identifiers & GS1 Standards Recommendations on Medical Device and IVD Field Safety Corrective Actions and Recalls using Unique Device Identifiers & GS1 Standards January 2017 Contributors Name Andy Crosbie (Sub group chair) David

More information

First Global Forum on Medical Devices Bangkok-Thailand, September Regulatory Control of Medical Devices in Tanzania

First Global Forum on Medical Devices Bangkok-Thailand, September Regulatory Control of Medical Devices in Tanzania First Global Forum on Medical Devices Bangkok-Thailand, September 9-11 2010 Regulatory Control of Medical Devices in Tanzania Mr. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority hiiti@yahoo.com/hiiti.sillo@tfda.or.tz

More information

Your Vision, Our Future Korean Medical Device Your Vision, Our Future

Your Vision, Our Future Korean Medical Device Your Vision, Our Future www.mfds.go.kr/eng Your Vision, Our Future Korean Korean Your Vision, Our Future 01 Passion for Growth & Excellence With a 5% average annual growth rate, the Korean medical device market was valued at

More information

Software Regulation: The Transfusion Medicine Experience

Software Regulation: The Transfusion Medicine Experience AMIA Invitational Policy Meeting September 9-10, 2009 Software Regulation: The Transfusion Medicine Experience Rodeina Davis Vice President & CIO Milwaukee, WI Founded 60 Years Ago, BloodCenter of Wisconsin

More information

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil

More information

INTRODUCTION. How we regulate Cell and Gene Therapy Product? Presented by Azizah Ab Ghani National Pharmaceutical Control Bureau

INTRODUCTION. How we regulate Cell and Gene Therapy Product? Presented by Azizah Ab Ghani National Pharmaceutical Control Bureau INTRODUCTION How we regulate Cell and Gene Therapy Product? Presented by Azizah Ab Ghani National Pharmaceutical Control Bureau 1 CGTP Multidisciplinary approach MOH Medical Development Division Medical

More information

The Top 5 Mistakes in Making a Declaration of Conformity for CE Marking

The Top 5 Mistakes in Making a Declaration of Conformity for CE Marking Intertek Cleeve Road, Leatherhead, Surrey KT22 7SB UK info.uk@intertek.com 01372 370900 www.intertek.com Contents Introduction... 2 The top 5 mistakes in making a Declaration of Conformity... 3 1. Not

More information

Update on GCC Region. 8 May Prof. Saleh Bawazir Vice President for Drug Affairs Saudi Food and Drug Authority Riyadh, Saudi Arabia

Update on GCC Region. 8 May Prof. Saleh Bawazir Vice President for Drug Affairs Saudi Food and Drug Authority Riyadh, Saudi Arabia Update on GCC Region ICH-GCG Meeting, Brussels 8 May 2007 Prof. Saleh Bawazir Vice President for Drug Affairs Saudi Food and Drug Authority Riyadh, Saudi Arabia 1 Three meetings were conducted since November

More information

Korea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon

Korea GMP & DMF. April Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon Korea GMP & DMF April. 2015 Korea Pharmaceutical Traders Association Deputy director Oh Hyun, Kwon Contents 1. KPTA 2. Pharmaceutical industry 3. KGMP 4. KDMF KPTA KPTA Purpose ㅇ Trade promotion of pharmaceuticals,

More information

Building Effective National Strategies to Better Address Counterfeit Medicines

Building Effective National Strategies to Better Address Counterfeit Medicines Building Effective National Strategies to Better Address Counterfeit Medicines Expanding GMP, GDP, GPP, and Pharmacovigilance Systems ILISA B.G. BERNSTEIN, Pharm.D., J.D. Director of Pharmacy Affairs U.S.

More information

Title: Department: Approved by: Director, Human Research Review and Compliance

Title: Department: Approved by: Director, Human Research Review and Compliance Title: Department: Requirements for Investigational New Drug (IND) for Human- Subjects Research Human Research Affairs Policy Type: Partners System-wide Partners System-wide Template Partners HealthCare

More information

Approved by Resolution of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015

Approved by Resolution of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015 RESOLUTION of the Ministry of Health of the Republic of Belarus No. 55 dated April 23, 2015 On certain measures on realization of the Resolution of the Council of Ministers of the Republic of Belarus No.

More information

ON APPROVAL OF THE STATE COMMITTEE OF UZBEKISTAN FOR NATURE PROTECTION

ON APPROVAL OF THE STATE COMMITTEE OF UZBEKISTAN FOR NATURE PROTECTION RESOLUTION OLIY MAJLIS OF UZBEKISTAN ON APPROVAL OF THE STATE COMMITTEE OF UZBEKISTAN FOR NATURE PROTECTION (Bulletin of the Oliy Majlis of the Republic of Uzbekistan, 1996, 5-6, art. 70, 2000, 5-6, Art.

More information

Precision Medicine. Presented by:

Precision Medicine. Presented by: Precision Medicine Presented by: Prepared Brendan FitzGerald For: Enabling better health through information technology. Healthcare Information and Management Systems Society (HIMSS) HIMSS is a global,

More information

GUIDELINES ON MEDICAL DEVICES. IVD GUIDANCE : Research Use Only products A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES

GUIDELINES ON MEDICAL DEVICES. IVD GUIDANCE : Research Use Only products A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES Ref. Ares(2015)2031363-13/05/2015 EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology

More information

COUNTRY OVERVIEW: THAILAND. August 2012 SPECIAL REPRINT. By Rarana Phanudulkitti

COUNTRY OVERVIEW: THAILAND. August 2012 SPECIAL REPRINT. By Rarana Phanudulkitti August 2012 SPECIAL REPRINT COUNTRY OVERVIEW: THAILAND By Rarana Phanudulkitti Reproduced with the kind permission of Global Regulatory Press from the Journal of Medical Device Regulation, 2012, 9(3),

More information

Section I: Pharmaceuticals and Medical Devices

Section I: Pharmaceuticals and Medical Devices SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical

More information

Experimental Medical Device Studies in Canada

Experimental Medical Device Studies in Canada Experimental Medical Device Studies in Canada Stephen A Hoption Cann, PhD Clinical Professor Chair, UBC Clinical Research Ethics Board School of Population & Public Health University of British Columbia

More information

Bridging gaps: medical device directive vs regulation. Geert Corstens 1 November 2018

Bridging gaps: medical device directive vs regulation. Geert Corstens 1 November 2018 Bridging gaps: medical device directive vs regulation Geert Corstens 1 November 2018 Agenda Current Medical Device regulatory landscape New Medical Device Regulation EU Interaction & impact Medical device

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

Practical implementation of the Falsified Medicines Directive

Practical implementation of the Falsified Medicines Directive Practical implementation of the Falsified Medicines Directive Belén Escribano Romero Head of Pharmaceutical Inspection and Enforcement Department AEMPS 1 Content Development of the Directive Overview of

More information

DECREE - 8,077, OF AUGUST 14TH, 2013

DECREE - 8,077, OF AUGUST 14TH, 2013 DECREE - 8,077, OF AUGUST 14TH, 2013 Regulates the registro, control, and monitoring of the products addressed by Law 6,360, of September 23rd, 1976, and the conditions for the operation of companies subject

More information

Agenzia Italiana del Farmaco

Agenzia Italiana del Farmaco Agenzia Italiana del Farmaco European Regulation on Advanced Therapies Cristina Pintus Head of European Relations Unit and Coordinator of the Advanced Therapy Project Italian Medicines Agency Proposal

More information

Are Pharmaco- and Medical Device Vigilance the same?

Are Pharmaco- and Medical Device Vigilance the same? Are Pharmaco- and Medical Device Vigilance the same? And the new Medical Device Regulation (MDR) Benelux Pharmacovigilance Day, 17 Oct 2017 Jan Bart Hak COMPANY Qualified & Experienced Staff Divisions

More information

Considerations on regulatory aspects

Considerations on regulatory aspects Considerations on regulatory aspects Regulatory framework for medicinal products in the context of therapeutic use of bacteriophages EMA Workshop on 8 June Presented by Zigmars Sebris on 8 June 2015 Regulatory

More information

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,

More information

Organization and methodology of domestic trade statistics in the Russian Federation

Organization and methodology of domestic trade statistics in the Russian Federation Organization and methodology of domestic trade statistics in the Russian Federation 1. The trade is on of the major economic branches in terms of added value volume produced. It contributed 22% of Russian

More information